Skip to main content

Felicity Kalinowski

Home  >  Felicity Kalinowski

Research Officer

Felicity Kalinowski


Felicity Kalinowski completed her Undergraduate degree at the University of Western Australia in 2008. She completed and was awarded First Class Honours at UWA/Perkins in 2009. Felicity commenced as a Research Assistant at the Perkins in 2010. She joined the Translational Cancer Research Program in 2020 where she currently works on nucleic acid extraction, and sample preparation for Whole Exome Sequencing and RNAseq for the Liver Cancer Collaborative and Perkins Cancer Biobank.


Barker A, Giles KM, Epis MR, Zhang PM, Kalinowski F, Leedman PJ. 2010, ‘Regulation of ErbB receptor signalling in cancer cells by microRNA’, Curr. Opin. Pharmacol. 10:6 655-661.

Horsham JL, Ganda C, Kalinowski FC, Brown RAM, Epis MR, Leedman PJ. 2015, ‘MicroRNA-7: A miRNA with expanding roles in development and disease, Int. J. Biochem. Cell Biol. 69 215-224.

Horsham JL, Kalinowski FC, Epis MR, Ganda C, Brown RAM, Leedman PJ. 2015,’Clinical Potential of microRNA-7 in Cancer’. J. Clin. Med. 4, 1668-1687.

Kalinowski FC, Brown RA, Ganda C, Giles KM, Epis MR, Horsham J, Leedman PJ. 2014. ‘microRNA-7: a tumor suppressor miRNA with therapeutic potential’. Int J Biochem Cell Biol. 54:312-7.

Giles KM, Kalinowski FC, Candy PA, Epis MR, Zhang PM, Redfern AD, Stuart LM, Goodall GJ, Leedman PJ. ‘Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib’. 2013. Mol Cancer Ther. 12(11):2541-58.

Giles KM, Brown RA, Epis MR, Kalinowski FC, Leedman PJ. 2012. ‘miRNA-7-5p inhibits melanoma cell migration and invasion’. Biochem Biophys Res Commun. 430(2):706-10.

Kalinowski FC, Giles KM, Candy PA, Ali A, Ganda C, Epis MR, Webster RJ, Leedman PJ. 2012. ‘Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7’. PLoS One. 7(10):e47067.

Epis MR, Giles KM, Kalinowski FC, Barker A, Cohen RJ, Leedman PJ. 2012. ‘Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells’. J Biol Chem., 287(42):35251-35259.

Barker A, Giles KM, Epis MR, Zhang PM, Kalinowski F, Leedman PJ. 2010. ‘Regulation of ErbB receptor signalling in cancer cells by microRNA’. Curr Opin Pharmacol. 10(6):655-61.